Opportunistic Infections Citation List:
April 29 - May 12, 2011
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Exploration of Islamic Medicine Plant Extracts as Powerful Antifungals for the Prevention of Mycotoxigenic Aspergilli Growth in Organic Silage. Tayel, A.A., M.F. Salem, W.F. El-Tras, and L. Brimer. Journal of the Science of Food and Agriculture, 2011. [Epub ahead of print]; PMID[21547917].
[Pubmed]. OI_0427-051111.
2. Root Cultures of Hypericum perforatum subsp. angustifolium Elicited with Chitosan and Production of Xanthone-Rich Extracts with Antifungal Activity. Tocci, N., G. Simonetti, F.D. D'Auria, S. Panella, A.T. Palamara, A. Valletta, and G. Pasqua. Applied Microbiology and Biotechnology, 2011. [Epub ahead of print]; PMID[21547455].
[Pubmed]. OI_0427-051111.
3. Cryptococcus and Trichosporon spp. are Susceptible In Vitro to Branched Histidine- and Lysine-Rich Peptides (BHKPs). Verwer, P.E., M.C. Woodle, T. Boekhout, F. Hagen, I.A. Bakker-Woudenberg, and W.W. van de Sande. Journal of Antimicrobial Chemotherapy, 2011. [Epub ahead of print]; PMID[21543360].
[Pubmed]. OI_0427-051111.
4. Antitumor and Antimicrobial Activities of Endophytic Fungi from Medicinal Parts of Aquilaria sinensis. Cui, J.L., S.X. Guo, and P.G. Xiao. Journal of Zhejiang University Science. B., 2011. 12(5): p. 385-392; PMID[21528493].
[Pubmed]. OI_0427-051111.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
5. Antitubercular Chromones and Flavonoids from Pisonia aculeata. Wu, M.C., C.F. Peng, I.S. Chen, and I.L. Tsai. Journal of Natural Products, 2011. [Epub ahead of print]; PMID[21542597].
[Pubmed]. OI_0427-051111.
6. Curcumin Acts Synergistically with Fluconazole to Sensitize a Clinical Isolate of Candida albicans Showing a MDR Phenotype. Garcia-Gomes, A.S., J.A. Curvelo, R.M. Soares, and A. Ferreira-Pereira. Medical Mycology, 2011. [Epub ahead of print]; PMID[21539505].
[Pubmed]. OI_0427-051111.
7. Secondary Metabolites from the Root Wood of Zanthoxylum wutaiense and Their Antitubercular Activity. Huang, H.Y., T. Ishikawa, C.F. Peng, S. Chen, and I.S. Chen. Chemistry and Biodiversity, 2011. 8(5): p. 880-886; PMID[21560236].
[Pubmed]. OI_0427-051111.
8. Synthesis and Antimycobacterial Evaluation of N'-(E)-heteroaromaticpyrazine-2-carbohydrazide Derivatives. Lima, C.H., M.G. Henriques, A.L. Candea, M.C. Lourenco, F.A. Bezerra, M.L. Ferreira, C.R. Kaiser, and M.V. de Souza. Medicinal Chemistry, 2011. 7(3): p. 245-249; PMID[21486206].
[Pubmed]. OI_0427-051111.
9. Potent Inhibitors of a Shikimate Pathway Enzyme from Mycobacterium tuberculosis: Combining Mechanism - and Modeling-Based Design. Reichau, S., W. Jiao, S.R. Walker, R.D. Hutton, E.N. Baker, and E.J. Parker. Journal of Biological Chemistry, 2011. 286(18): p. 16197-16207; PMID[21454647].
[Pubmed]. OI_0427-051111.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
10. Evaluation of Turkish Seaweeds for Antiprotozoal, Antimycobacterial and Cytotoxic Activities. Suzgec-Selcuk, S., A.H. Mericli, K.C. Guven, M. Kaiser, R. Casey, S. Hingley-Wilson, A. Lalvani, and D. Tasdemir. Phytotherapy Research, 2011. 25(5): p. 778-783; PMID[21520472].
[Pubmed]. OI_0427-051111.
11. In Vitro and In Vivo Assessment of the Anti-Malarial Activity of Caesalpinia pluviosa and Analysis of its Active Fractions. Kayano, A.C., S.C. Lopes, F.G. Bueno, E.C. Cabral, W.C. Neiras, L.M. Yamauchi, M.A. Foglio, M.N. Eberlin, J.C. Mello, and F.T. Costa. Malaria Journal, 2011. 10(1): p. 112; PMID[21535894].
[Pubmed]. OI_0427-051111.
12. Potent Antiprotozoal Activity of a Novel Semi-Synthetic Berberine Derivative. Bahar, M., Y. Deng, X. Zhu, S. He, T. Pandharkar, M.E. Drew, A. Navarro-Vazquez, C. Anklin, R.R. Gil, R.W. Doskotch, K.A. Werbovetz, and A.D. Kinghorn. Bioorganic & Medicinal Chemistry Letters, 2011. 21(9): p. 2606-2610; PMID[21474310].
[Pubmed]. OI_0427-051111.
13. In Vitro Activity of New Artemisinin Derivatives Against Plasmodium falciparum Clinical Isolates from Gabon. Held, J., S.A. Soomro, P.G. Kremsner, F.H. Jansen, and B. Mordmuller. International Journal of Antimicrobial Agents, 2011. 37(5): p. 485-488; PMID[21392942].
[Pubmed]. OI_0427-051111.
14. In Vitro and In Vivo Antiplasmodial Activities of Risedronate and Its Interference with Protein Prenylation in Plasmodium falciparum. Jordao, F.M., A.Y. Saito, D.C. Miguel, V. de Jesus Peres, E.A. Kimura, and A.M. Katzin. Antimicrobial Agents and Chemotherapy, 2011. 55(5): p. 2026-2031; PMID[21357292].
[Pubmed]. OI_0427-051111.
15. In Vitro Activity of Proveblue (Methylene Blue) on Plasmodium falciparum Strains Resistant to Standard Antimalarial Drugs. Pascual, A., M. Henry, S. Briolant, S. Charras, E. Baret, R. Amalvict, E. Huyghues des Etages, M. Feraud, C. Rogier, and B. Pradines. Antimicrobial Agents and Chemotherapy, 2011. 55(5): p. 2472-2474; PMID[21343466].
[Pubmed]. OI_0427-051111.
16. An Unusual Dimeric Guaianolide with Antiprotozoal Activity and Further Sesquiterpene Lactones from Eupatoriumperfoliatum. Maas, M., A. Hensel, F.B. Costa, R. Brun, M. Kaiser, and T.J. Schmidt. Phytochemistry, 2011. 72(7): p. 635-644; PMID[21329950].
[Pubmed]. OI_0427-051111.
17. Antiplasmodial Volatile Extracts from Cleistopholis patens Engler & Diels and Uvariastrum pierreanum Engl. (Engl. & Diels) (Annonaceae) Growing in Cameroon. Boyom, F.F., V. Ngouana, E.A. Kemgne, P.H. Zollo, C. Menut, J.M. Bessiere, J. Gut, and P.J. Rosenthal. Parasitology Research, 2011. 108(5): p. 1211-1217; PMID[21107862].
[Pubmed]. OI_0427-051111.
18. Antiplasmodial Activity of Botanical Extracts Against Plasmodium falciparum. Bagavan, A., A.A. Rahuman, C. Kamaraj, N.K. Kaushik, D. Mohanakrishnan, and D. Sahal. Parasitology Research, 2011. 108(5): p. 1099-1109; PMID[21079994].
[Pubmed]. OI_0427-051111.
Citations from the ISI Web of Knowledge Listings for O.I.
19. Biochemical Characterization of Anti-microbial Activity of Glycolipids Produced by Rhodococcus Erythropolis. Abdel-Megeed, A., A.N. Al-Rahma, A.A. Mostafa, and K.H.C. Baser. Pakistan Journal of Botany, 2011. 43(2): p. 1323-1334; ISI[000289546300064].
[WOS]. OI_0427-051111.
20. Optimization of 3-Pphenylthio)quinolinium Compounds Against Opportunistic Fungal Pathogens. Boateng, C.A., X.Y. Zhu, M.R. Jacob, S.I. Khan, L.A. Walker, and S.Y. Ablordeppey. European Journal of Medicinal Chemistry, 2011. 46(5): p. 1789-1797; ISI[000289655100037].
[WOS]. OI_0427-051111.
21. Ethionamide Boosters: Synthesis, Biological Activity, and Structure-Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors. Flipo, M., M. Desroses, N. Lecat-Guillet, B. Dirie, X. Carette, F. Leroux, C. Piveteau, F. Demirkaya, Z. Lens, P. Rucktooa, V. Villeret, T. Christophe, H.K. Jeon, C. Locht, P. Brodin, B. Deprez, A.R. Baulard, and N. Willand. Journal of Medicinal Chemistry, 2011. 54(8): p. 2994-3010; ISI[000289697800034].
[WOS]. OI_0427-051111.
22. Design of Anti-Parasitic and Anti-Fungal Hydroxy-naphthoquinones that are Less Susceptible to Drug Resistance. Hughes, L.M., C.A. Lanteri, M.T. O'Neil, J.D. Johnson, G.W. Gribble, and B.L. Trumpower. Molecular and Biochemical Parasitology, 2011. 177(1): p. 12-19; ISI[000289338000002].
[WOS]. OI_0427-051111.
23. Identification and Characterization of Antimicrobial Peptides from the Skin of the Endangered Frog Odorrana ishikawae. Iwakoshi-Ukena, E., K. Ukena, A. Okimoto, M. Soga, G. Okada, N. Sano, T. Fujii, Y. Sugawara, and M. Sumida. Peptides, 2011. 32(4): p. 670-676; ISI[000289707300006].
[WOS]. OI_0427-051111.
24. Identification of Novel Potential Antibiotics for Tuberculosis by In Silico Structure-Based Drug Screening. Izumizono, Y., S. Arevalo, Y. Koseki, M. Kuroki, and S. Aoki. European Journal of Medicinal Chemistry, 2011. 46(5): p. 1849-1856; ISI[000289655100045].
[WOS]. OI_0427-051111.
25. Identification of Mannich Base as a Novel Inhibitor of Mycobacterium Tuberculosis Isocitrate by High-Throughput Screening. Ji, L., Q.X. Long, D.C. Yang, and J.P. Xie. International Journal of Biological Sciences, 2011. 7(3): p. 376-382; ISI[000289355700013].
[WOS]. OI_0427-051111.
26. Spectral, Biological Screening, and DNA Studies of Metal Chelates of 4- N,N-bis-(3,5-Dimethyl-pyrazolyl-1-methyl) aminoantipyrine. Kalanithi, M., M. Rajarajan, and P. Tharmaraj. Journal of Coordination Chemistry, 2011. 64(8): p. 1436-1445; ISI[000289572500011].
[WOS]. OI_0427-051111.
27. Antimicrobial Activity Screening of Isolated Flavonoids from Azadirachta indica Leaves. Kanwal, Q., I. Hussain, H.L. Siddiqui, and A. Javaid. Journal of the Serbian Chemical Society, 2011. 76(3): p. 375-384; ISI[000289270000006].
[WOS]. OI_0427-051111.
28. Synthesis of Some New Chalcones, Pyrazolines and Acetyl Pyrazolines Derived from Piperonal and Halogenohydroxy Acetophenones as Antimicrobial Agents. Karamunge, K.G., M.A. Sayyed, A.Y. Vibhute, and Y.B. Vibhute. Journal of the Indian Chemical Society, 2011. 88(3): p. 443-450; ISI[000289542800018].
[WOS]. OI_0427-051111.
29. Antifungal Activity of Essential Oils and Their Synergy with Fluconazole Against Drug-Resistant Strains of Aspergillus fumigatus and Trichophyton rubrum. Khan, M.S.A. and I. Ahmad. Applied Microbiology and Biotechnology, 2011. 90(3): p. 1083-1094; ISI[000289520000028].
[WOS]. OI_0427-051111.
30. Synthesis, Spectral Analysis, and Molecular Modeling of Bioactive Sn(II)-Complexes with Oxadiazole Schiff Bases. Khedr, A.M., S. Jadon, and V. Kumar. Journal of Coordination Chemistry, 2011. 64(8): p. 1351-1359; ISI[000289572500004].
[WOS]. OI_0427-051111.
31. Chemistry and Biology of Macrolide Antiparasitic Agents. Lee, Y., J.Y. Choi, H. Fu, C. Harvey, S. Ravindran, W.R. Roush, J.C. Boothroyd, and C. Khosla. Journal of Medicinal Chemistry, 2011. 54(8): p. 2792-2804; ISI[000289697800018].
[WOS]. OI_0427-051111.
32. The Effect of Baccharis Glutinosa Extract on the Growth of Mycotoxigenic Fungi and Fumonisin B-1 and Aflatoxin B-1 Production. Rosas-Burgos, E.C., M.O. Cortez-Rocha, M. Plascencia-Jatomea, F.J. Cinco-Moroyoqui, R.E. Robles-Zepeda, J. Lopez-Cervantes, D.I. Sanchez-Machado, and F. Lares-Villa. World Journal of Microbiology & Biotechnology, 2011. 27(5): p. 1025-1033; ISI[000289684200003].
[WOS]. OI_0427-051111.
33. Design and Synthesis of Antifungal Benzoheterocyclic Derivatives by Scaffold Hopping. Sheng, C.Q., X.Y. Che, W.Y. Wang, S.Z. Wang, Y.B. Cao, J.Z. Yao, Z.Y. Miao, and W.N. Zhang. European Journal of Medicinal Chemistry, 2011. 46(5): p. 1706-1712; ISI[000289655100028].
[WOS]. OI_0427-051111.
34. Chemical Composition and Antifungal Activity of Essential Oil from Cicuta virosa L. var. latisecta Celak. Tian, J., X.Q. Ban, H. Zeng, J.S. He, B. Huang, and Y.W. Wang. International Journal of Food Microbiology, 2011. 145(2-3): p. 464-470; ISI[000289330400014].
[WOS]. OI_0427-051111.
35. Design Synthesis and Biological Evaluation of 3-Substituted Triazole Derivatives. Wang, B.G., S.C. Yu, X.Y. Chai, Y.Z. Yan, H.G. Hu, and Q.Y. Wu. Chinese Chemical Letters, 2011. 22(5): p. 519-522; ISI[000289336300005].
[WOS]. OI_0427-051111.